1. The relationship between receptor-effector unit heterogeneity and the shape of the concentration-effect profile: Pharmacodynamic implications

   • Amnon Hoffman
   • Assaf Goldberg

   OriginalPaper 17 January 1995 Pages: 449 - 468

2. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking

   • Mark A. Milad
   • Elizabeth A. Ludwig
   • William J. Jusko

   OriginalPaper 18 January 1995 Pages: 469 - 480

3. Pharmacokinetics of bupivacaine enantiomers in sheep: Influence of dosage regimen and study design

   • Laurence E. Mather
   • Albert J. Rutten
   • John L. Plummer

   OriginalPaper 25 January 1995 Pages: 481 - 498

4. Pharmacodynamic analysis of hematologic profiles

   • Gary L. Rosner
   • Peter Müller

   OriginalPaper 15 March 1995 Pages: 499 - 524

5. Comparison of some control strategies for three-compartment PK/PD models

   • Chuanpu Hu
   • William S. Lovejoy
   • Steven L. Shafer

   OriginalPaper 18 January 1995 Pages: 525 - 550

6. Measuring switchability and prescribability: When is average bioequivalence sufficient?

   • Walter W. Hauck
   • Sharon Anderson

   OriginalPaper 28 December 1994 Pages: 551 - 564

7. Simple approximate formulas for calculating the time to clear drug and the time to accumulate drug when the plasma disposition curve of the drug is multiexponential

   • Dennis A. Noe

   Letter to the Editor 28 February 1995 Pages: 565 - 567

8. Announcements

   Announcement 01 December 1994 Pages: 569 - 569